Enlivex Therapeutics To Present At The 21st Annual Global Investment Conference, Sponsored By H.C. Wainwright & Co.
September 04 2019 - 7:30AM
Enlivex Therapeutics Ltd. (Nasdaq:ENLV), a clinical-stage
immunotherapy company, today announced that company management will
make a corporate presentation at the 21st Annual Global Investment
Conference, sponsored by H.C. Wainwright & Co., being held at
the Lotte New York Palace Hotel in New York. The presentation is
scheduled for September 9th 2019 at 2:10pm local time. To join the
live webcast, please click http://wsw.com/webcast/hcw5/enlv/ and
register prior to the presentation time.
ALLOCETRATM by Enlivex was designed to provide a novel
immunotherapy mechanism of action that targets
life-threatening clinical indications that are defined as “unmet
medical needs”, including prevention or treatment of
complications associated with bone marrow transplantations (BMT)
and/or hematopoietic stem cell transplantations (HSCT); organ
dysfunction and acute multiple organ failure associated with
Sepsis; and enablement of an effective treatment of solid tumors
via immune checkpoint rebalancing.
For more information about the 21st Annual Global Investment
Conference, sponsored by H.C. Wainwright & Co., visit
http://www.rodmanevents.com/
ABOUT ENLIVEXEnlivex is a clinical stage immunotherapy
company, developing an allogeneic drug pipeline for immune system
rebalancing. Immune system rebalancing is critical for the
treatment of life-threatening immune and inflammatory conditions
which involve an out of control immune system (e.g. Cytokine
Release Syndrome) and for which there are no approved treatments
(unmet medical needs), as well as solid tumors immune-checkpoint
rebalancing. For more information, visit
http://www.enlivex.com.
ENLIVEX CONTACT:
Shachar Shlosberger, CFO
Enlivex Therapeutics,
Ltd.
shachar@enlivex-pharm.com
Enlivex Therapeutics (NASDAQ:ENLV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Enlivex Therapeutics (NASDAQ:ENLV)
Historical Stock Chart
From Apr 2023 to Apr 2024